United States (US) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters, Implantable Ports and Infusion Systems

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: June 23, 2025 Report Code: GDME0618MDB-ST

Select Item

GlobalData’s “United States Drug Delivery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Infusion Systems, Central Venous Catheters and Implantable Ports

The United States Drug Delivery Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Drug Delivery Devices Market.
• Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Drug Delivery Devices is segmented as follows – _x000D_

• Infusion Systems_x000D_

• Central Venous Catheters _x000D_

• Implantable Ports

Reasons to Buy

The United States Drug Delivery Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

B. Braun Melsungen AG_x000D_
Becton Dickinson and Co_x000D_
Teleflex Inc_x000D_
Baxter International Inc_x000D_
ICU Medical Inc_x000D_
Edwards Lifesciences Corp_x000D_
Vygon SA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 13

|1.2 List of Figures 13

2 Introduction 15

2.1 What Is This Report About? 15

2.2 Drug Delivery Devices Market Segmentation 15

2.3 Definitions of Markets Covered in the Report 16

3 Drug Delivery Devices Market, United States 18

3.1 Drug Delivery Devices Market, United States, Revenue ($m), 2018-2033 18

3.2 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2023 19

3.3 Drug Delivery Devices Market, United States, Category Contribution by Revenue ($m), 2023 20

3.4 Drug Delivery Devices Market, United States, Revenue ($m), 2018-2033 21

3.5 Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 23

3.6 Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 24

3.7 Drug Delivery Devices Market, United States, Company Share by Revenue ($m), 2023 26

4 Central Venous Catheters Market, United States 28

4.1 Central Venous Catheters Market, United States, Revenue Mix ($m), 2023 28

4.2 Central Venous Catheters Market, United States, Segment Contribution (%), 2023 29

4.3 Central Venous Catheters Market, United States, Revenue ($m), 2018-2033 30

4.4 Central Venous Catheters Market, United States, Volume (Units), 2018-2033 32

4.5 Central Venous Catheters Market, United States, Average Price ($) , 2018-2033 34

4.6 Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), 2023 35

4.7 Central Venous Catheters Market, United States, Company Share by Revenue ($m), 2023 36

5 Implantable Ports Market, United States 37

5.1 Implantable Ports Market, United States, Revenue Mix ($m), 2023 37

5.2 Implantable Ports Market, United States, Segment Contribution (%), 2023 38

5.3 Implantable Ports Market, United States, Revenue ($m), 2018-2033 39

5.4 Implantable Ports Market, United States, Volume (Units), 2018-2033 41

5.5 Implantable Ports Market, United States, Average Price ($) , 2018-2033 43

5.6 Implantable Ports Market, United States, Distribution Share by Revenue ($m), 2023 44

5.7 Implantable Ports Market, United States, Company Share by Revenue ($m), 2023 45

6 Infusion Systems Market, United States 46

6.1 Infusion Systems Market, United States, Revenue Mix ($m), 2023 46

6.2 Infusion Systems Market, United States, Segment Contribution (%), 2023 47

6.3 Infusion Systems Market, United States, Revenue ($m), 2018-2033 48

6.3.1 Infusion Pump Disposables Market, United States, Revenue ($m), by Segment, 2018-2033 50

6.3.2 Infusion Pumps Market, United States, Revenue ($m), by Segment, 2018-2033 52

6.4 Infusion Systems Market, United States, Volume (Units), 2018-2033 53

6.4.1 Infusion Pump Disposables Market, United States, Volume (Units), by Segment, 2018-2033 55

6.4.2 Infusion Pumps Market, United States, Volume (Units), by Segment, 2018-2033 57

6.5 Infusion Systems Market, United States, Average Price ($) , 2018-2033 59

6.6 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2023 60

6.7 Infusion Systems Market, United States, Company Share by Revenue ($m), 2023 61

7 Overview of Key Companies in United States, Drug Delivery Devices Market 62

7.1 Becton Dickinson and Co 62

7.1.1 Company Overview 62

7.2 B. Braun Melsungen AG 62

7.2.1 Company Overview 62

7.3 Teleflex Inc 62

7.3.1 Company Overview 62

7.4 ICU Medical Inc 62

7.4.1 Company Overview 62

7.5 Baxter International Inc 63

7.5.1 Company Overview 63

7.6 Vygon SA 63

7.6.1 Company Overview 63

7.7 Edwards Lifesciences Corp 63

7.7.1 Company Overview 63

8 Drug Delivery Devices Market Pipeline Products 64

9 Financial Deals Landscape 72

9.1 Acquisition 72

9.1.1 Starboard Value May Acquire Stake in Pfizer for USD1 Billion 72

9.1.2 Eimo Technologies and Nissha Eimo Acquisition Acquire Majority Stake in Cathtek for USD18 Million 73

9.1.3 Quantiphi Acquires Minority Stake in Transcell Technology 74

9.1.4 Crown Laboratories Acquires Revance Therapeutics for USD924 Million 75

9.1.5 Smiths Group Sells

4.9% Stake in ICU Medical For USD152 Million 77

9.1.6 Exeltis USA Acquires Agile Therapeutics for Approximately USD45 Million 78

9.1.7 ToxStrategies Acquires Clintrex Research 80

9.1.8 DuPont de Nemours Acquires Donatelle Plastics 82

9.1.9 ANI Pharma Acquires Alimera Sciences for Approximately USD381 Million 84

9.1.10 Serum Institute of India Acquires 20% Stake in IntegriMedical 86

9.1.11 Gerresheimer Acquires Minority Stake in RxCap 88

9.2 Asset Transactions 89

9.2.1 Merit Medical Acquires Lead Management Portfolio from Cook Medical for USD210 Million 89

9.2.2 SERB Pharma Acquires Reactive Skin Decontamination Lotion (RSDL) Kit from Emergent BioSolutions 91

9.2.3 Sharps Technology Acquires InjectEZ from Nephron Pharma 93

9.3 Debt Offerings 94

9.3.1 Stryker Raises USD883.83 Million Public Offering of

3.375% Notes Due 2032 94

9.3.2 Stryker Raises USD662.87 Million in Public Offering of

3.625% Notes Due 2036 96

10 Recent Developments 97

11 Appendix 105

Table

Table 1: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 18

Table 2: Drug Delivery Devices Market, United States, Category Contribution by Revenue ($m), 2023 20

Table 3: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 22

Table 4: Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 23

Table 5: Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 25

Table 6: Drug Delivery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 27

Table 7: Central Venous Catheters Market, United States, Segment Contribution (%), 2023 29

Table 8: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033 31

Table 9: Central Venous Catheters Market, United States, Volume (Units), 2018-2033 33

Table 10: Central Venous Catheters Market, United States, Average Price ($), 2018-2033 34

Table 11: Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023 35

Table 12: Central Venous Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2023 36

Table 13: Implantable Ports Market, United States, Segment Contribution (%), 2023 38

Table 14: Implantable Ports Market, United States, Revenue ($m), USD Constant, 2018-2033 40

Table 15: Implantable Ports Market, United States, Volume (Units), 2018-2033 42

Table 16: Implantable Ports Market, United States, Average Price ($), 2018-2033 43

Table 17: Implantable Ports Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023 44

Table 18: Implantable Ports Market, United States, Company Share by Revenue ($m), USD Constant, 2023 45

Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2023 47

Table 20: Infusion Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 49

Table 21: Infusion Pump Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033 51

Table 22: Infusion Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033 52

Table 23: Infusion Systems Market, United States, Volume (Units), 2018-2033 54

Table 24: Infusion Pump Disposables Market, United States, Volume (Units), 2018-2033 56

Table 25: Infusion Pumps Market, United States, Volume (Units), 2018-2033 58

Table 26: Infusion Systems Market, United States, Average Price ($), 2018-2033 59

Table 27: Infusion Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023 60

Table 28: Infusion Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2023 61

Table 29: Drug Delivery Devices Market Pipeline Products 64

Table 30: Starboard Value May Acquire Stake in Pfizer for USD1 Billion 72

Table 31: Eimo Technologies and Nissha Eimo Acquisition Acquire Majority Stake in Cathtek for USD18 Million 73

Table 32: Quantiphi Acquires Minority Stake in Transcell Technology 74

Table 33: Crown Laboratories Acquires Revance Therapeutics for USD924 Million 75

Table 34: Smiths Group Sells 4.9% Stake in ICU Medical For USD152 Million 77

Table 35: Exeltis USA Acquires Agile Therapeutics for Approximately USD45 Million 78

Table 36: ToxStrategies Acquires Clintrex Research 80

Table 37: DuPont de Nemours Acquires Donatelle Plastics 82

Table 38: ANI Pharma Acquires Alimera Sciences for Approximately USD381 Million 84

Table 39: Serum Institute of India Acquires 20% Stake in IntegriMedical 86

Table 40: Gerresheimer Acquires Minority Stake in RxCap 88

Table 41: Merit Medical Acquires Lead Management Portfolio from Cook Medical for USD210 Million 89

Table 42: SERB Pharma Acquires Reactive Skin Decontamination Lotion (RSDL) Kit from Emergent BioSolutions 91

Table 43: Sharps Technology Acquires InjectEZ from Nephron Pharma 93

Table 44: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032 94

Table 45: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036 96

Table 46: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country 283

Figures

Figure 1: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 18

Figure 2: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2023 19

Figure 3: Drug Delivery Devices Market, United States, Category Contribution (%), 2023 20

Figure 4: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 21

Figure 5: Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 23

Figure 6: Drug Delivery Devices Market, United States, Volume (Units), 2018-2033 24

Figure 7: Drug Delivery Devices Market, United States, Company Share (%) 2023 26

Figure 8: Central Venous Catheters Market, United States, Revenue Mix ($m), 2023 28

Figure 9: Central Venous Catheters Market, United States, Segment Contribution (%), 2023 29

Figure 10: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033 30

Figure 11: Central Venous Catheters Market, United States, Volume (Units), 2018-2033 32

Figure 12: Central Venous Catheters Market, United States, Company Share (%) 2023 36

Figure 13: Implantable Ports Market, United States, Revenue Mix ($m), 2023 37

Figure 14: Implantable Ports Market, United States, Segment Contribution (%), 2023 38

Figure 15: Implantable Ports Market, United States, Revenue ($m), USD Constant, 2018-2033 39

Figure 16: Implantable Ports Market, United States, Volume (Units), 2018-2033 41

Figure 17: Implantable Ports Market, United States, Company Share (%) 2023 45

Figure 18: Infusion Systems Market, United States, Revenue Mix ($m), 2023 46

Figure 19: Infusion Systems Market, United States, Segment Contribution (%), 2023 47

Figure 20: Infusion Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 48

Figure 21: Infusion Pump Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033 50

Figure 22: Infusion Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033 52

Figure 23: Infusion Systems Market, United States, Volume (Units), 2018-2033 53

Figure 24: Infusion Pump Disposables Market, United States, Volume (Units), 2018-2033 55

Figure 25: Infusion Pumps Market, United States, Volume (Units), 2018-2033 57

Figure 26: Infusion Systems Market, United States, Company Share (%) 2023 61

United States (US) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters, Implantable Ports and Infusion Systems standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (US) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters, Implantable Ports and Infusion Systems in real time.

  • Access a live United States (US) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters, Implantable Ports and Infusion Systems dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more